Stock Analysis

Is Iljin Display (KRX:020760) Weighed On By Its Debt Load?

KOSE:A020760
Source: Shutterstock

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We note that Iljin Display Co., Ltd. (KRX:020760) does have debt on its balance sheet. But should shareholders be worried about its use of debt?

Why Does Debt Bring Risk?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. When we examine debt levels, we first consider both cash and debt levels, together.

See our latest analysis for Iljin Display

What Is Iljin Display's Net Debt?

The image below, which you can click on for greater detail, shows that Iljin Display had debt of ₩60.9b at the end of September 2023, a reduction from ₩68.2b over a year. On the flip side, it has ₩7.59b in cash leading to net debt of about ₩53.3b.

debt-equity-history-analysis
KOSE:A020760 Debt to Equity History March 26th 2024

How Healthy Is Iljin Display's Balance Sheet?

According to the last reported balance sheet, Iljin Display had liabilities of ₩71.9b due within 12 months, and liabilities of ₩17.5b due beyond 12 months. Offsetting these obligations, it had cash of ₩7.59b as well as receivables valued at ₩5.78b due within 12 months. So its liabilities total ₩76.0b more than the combination of its cash and short-term receivables.

When you consider that this deficiency exceeds the company's ₩62.2b market capitalization, you might well be inclined to review the balance sheet intently. Hypothetically, extremely heavy dilution would be required if the company were forced to pay down its liabilities by raising capital at the current share price. The balance sheet is clearly the area to focus on when you are analysing debt. But it is Iljin Display's earnings that will influence how the balance sheet holds up in the future. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

In the last year Iljin Display had a loss before interest and tax, and actually shrunk its revenue by 56%, to ₩54b. That makes us nervous, to say the least.

Caveat Emptor

While Iljin Display's falling revenue is about as heartwarming as a wet blanket, arguably its earnings before interest and tax (EBIT) loss is even less appealing. Indeed, it lost a very considerable ₩8.0b at the EBIT level. When we look at that alongside the significant liabilities, we're not particularly confident about the company. It would need to improve its operations quickly for us to be interested in it. Not least because it burned through ₩10b in negative free cash flow over the last year. That means it's on the risky side of things. The balance sheet is clearly the area to focus on when you are analysing debt. However, not all investment risk resides within the balance sheet - far from it. For instance, we've identified 3 warning signs for Iljin Display (1 is potentially serious) you should be aware of.

At the end of the day, it's often better to focus on companies that are free from net debt. You can access our special list of such companies (all with a track record of profit growth). It's free.

Valuation is complex, but we're helping make it simple.

Find out whether Iljin Display is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.